Wockhardt Limited (NSE:WOCKPHARMA)
India · Delayed Price · Currency is INR | Market Cap | 308.91B +45.5% |
| Revenue (ttm) | 36.53B +20.4% |
| Net Income | 4.09B |
| EPS | 25.19 |
| Shares Out | 162.49M |
| PE Ratio | 74.71 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 506,615 |
| Open | 1,923.00 |
| Previous Close | 1,922.90 |
| Day's Range | 1,872.00 - 1,932.90 |
| 52-Week Range | 1,086.70 - 2,422.30 |
| Beta | 1.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 2, 2026 |
About Wockhardt
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafith... [Read more]
Financial Performance
Financial StatementsNews
Wockhardt Quarterly report: Q1 2027
Wockhardt has published its Q1 2027 quarterly earnings report on August 10, 2026.
Pharma sector stocks today, July 1: Panacea Biotec surges 4.30%, Biocon jumps 1.78%, Wockhardt up 1.66%
The Indian pharmaceutical sector displayed mixed performance in early trading on July 1, 2026. The S&P BSE Healthcare index stood at 49,349.56, up 0.09%. Broader market indices also opened positively,...
Pharma sector stocks trade mixed on June 22: Cipla up 2.23%, Indoco Remedies gains 2.38%, Wockhardt falls 1.41%
Pharma stocks traded mixed on June 22, 2026, during the early morning session, with gains and losses spread across the sector. The broader market was positive, with the Nifty 50…
Pharma sector stocks today on June 22: Cipla up 2.23%, Indoco Remedies gains 2.38%, Wockhardt falls 1.41%
Pharma stocks traded mixed on June 22, 2026, during the early morning session, with gains and losses spread across the sector. The broader market was positive, with the Nifty 50…
Pharma sector stocks rises today, June 18: Wockhardt up 2.86%, Natco Pharma gains 2.38%, Panacea Biotech rises 2.01%
Pharma stocks traded broadly in positive territory on June 18, 2026, during the early morning session, with most stocks posting gains. The broader market was largely flat, with the Nifty…
Pharma sector stocks rise today, June 12: Panacea Biotech gains 2.50%, Wockhardt rises 2.24%, Natco Pharma up 1.36%
Pharma stocks traded broadly in positive territory on June 12, 2026, during the early morning session, with most stocks posting gains. The broader market was also strong, with the Nifty…
Top gainers in morning trade: aegis logistics at ₹891.50 up 11.30%, wockhardt at ₹1,927.00 up 5.13%, DOMS industries at ₹2,219.90 up 4.78%
The Indian stock market opened with a slight decline today, with the Sensex at 73,886.41, down 0.13%, and the Nifty 50 at 23,182.65, down 0.14%. Despite the overall market mood,…
Pharma sector stocks surge today, June 11: Wockhardt up 2.41%, Strides Pharma gains 2.10%, Indoco Remedies rises 2.58%
Pharma stocks traded largely in positive territory on June 11, 2026, during the early morning session, with most stocks posting gains even as the broader market remained weak. The Nifty…
Pharma sector stocks today, June 10: Panacea Biotech falls 8.09%, Wockhardt declines 1.47%, Alembic Pharma up 1.02%
Pharma stocks traded mixed on June 10, 2026, during the early morning session, with gains and losses spread across the sector. The broader market was positive, with the Nifty 50…
Top losers today: wockhardt at ₹1,920.90 down 7.33%, gujarat state petronet at ₹268.35 falls 7.13%, hindustan zinc at ₹566.80 slips 6.14%
The Indian stock market saw a decline today with the SENSEX at 74,243.34, down 0.16%, and the NIFTY 50 at 23,366.70, down 0.21%. Among the top losers were Wockhardt, Gujarat…
Top losers in morning trade: gujarat state petronet at ₹268.35 down 7.13%, wockhardt at ₹1,932.60 down 6.77%, HFCL at ₹187.23 down 5.00%
The Indian stock market opened with a mixed sentiment as the Sensex edged up by 0.18% to 74,497.34, while the Nifty 50 saw a modest increase of 0.13% to 23,447.00.…
Pharma sector stocks today, June 5: Panacea Biotech up 6.14%, Wockhardt falls 6.49%, Natco Pharma down 1.79%
Pharma stocks traded mixed on June 5, 2026, during the late morning session, with a majority of stocks posting gains while a handful remained under selling pressure. The broader market…
Wockhardt Transcript: Status update
The group has transformed into an innovation-led healthcare company, achieving strong financial growth and launching Zaynich, a novel antibiotic with global potential. Zaynich targets resistant infections, with a robust U.S. and India launch strategy, and aims for $1.5–$2 billion peak annual sales.
Wockhardt Slides: Status update
Wockhardt has posted slides in relation to its latest quarterly earnings report, which was published on June 4, 2026.
Pharma sector stocks today, June 4: Panacea Biotech up 7.24%, Wockhardt gains 3.09%, Natco Pharma falls 1.63%
Pharma stocks traded mixed on June 4, 2026, during the early morning session, with several stocks posting gains while others remained under mild selling pressure. The broader market was relatively…
Top losers today: wockhardt at ₹1,966.20 down 8.67%, gujarat state petronet at ₹268.35 falls 7.13%, NHPC at ₹72.29 slips 6.36%
In today's trading session, the Indian stock market showed a mixed performance with the SENSEX rising by 0.52% to 74,649.84 and the NIFTY 50 increasing by 0.43% to 23,483.55. Despite…
Top losers in morning trade: RHIM at ₹338.35 down 7.35%, wockhardt at ₹1,996 down 7.29%, GSPL at ₹268.35 down 7.13%
The Indian stock market witnessed a subdued session this morning, with both the Sensex and Nifty 50 showing slight declines. The Sensex stood at 74,214.07, down by 0.07%, while the…
Pharma sector stocks fall today, June 2: Wockhardt crashes 6.23%, Torrent Pharma down 2.06%, Ajanta Pharma down 1.96%
Pharmaceutical stocks traded mostly lower during the morning session on June 2, 2026. The BSE Healthcare index declined 0.81% to 46,088.65.The Nifty 50 was down 0.31% at 23,309.85, and the…
Pharma Stocks Today, June 1: Wockhardt surges 12%, Natco Pharma crashes 6%, Glenmark Pharma down 3.63%
Pharmaceutical stocks traded mixed on June 1, 2026, during the early morning session. While a few stocks like Wockhardt and Sudeep Pharma posted strong gains, several others, including Natco Pharma…
Wockhardt shares jump over 12% after US FDA approves Novel Antibiotic ZAYNICH
Wockhardt Ltd. shares jumped more than 12% in intraday trade after the company announced that the U.S. Food and Drug Administration (FDA) has approved ZAYNICH™ (cefepime and zidebactam), a novel…
Wockhardt receives U.S. FDA approval for ZAYNICH, a novel antibiotic for cUTI
Wockhardt has announced that it has received approval from the U.S. Food and Drug Administration (FDA) for ZAYNICH™ (cefepime and zidebactam), a novel intravenous antibiotic designed to treat adult pa...
Top gainers today: netweb at ₹4,670.70 up 14.70%, wockhardt at ₹2,031.40 up 14.70%, thermax at ₹4,982.70 up 8.54%
In a session marked by overall declines in the Indian stock market, with the Sensex dropping by 1.44% to 74,775.74 and the Nifty 50 falling by 1.50% to 23,547.75, a…
Top gainers in morning trade: netweb at ₹4,447 up 9.21%, wockhardt at ₹1,919.40 up 8.38%, thermax at ₹4,959.30 up 8.03%
The Indian stock market displayed a mixed performance in the morning session, with the Sensex inching up by 0.10% to 75,944.41, while the Nifty 50 saw a slight decline of…
Pharma sector stocks today, May 29: Wockhardt jumps 7.40%, Indoco Remedies rises 3.46%, Sudeep Pharma up 3.45%
The pharmaceutical stocks traded mixed on May 29, 2026, during the morning session. While some stocks like Wockhardt, Indoco Remedies, and Sudeep Pharma posted strong gains, a few others saw…
Wockhardt receives marketing authorisation for breakthrough antibiotic Zaynich in India
Wockhardt Ltd. has announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for its innovative antibiotic, Zaynich® (Zidebactam/Cefepime), in...